During the past decade, BioVirtus Centrum Medyczne conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "BioVirtus Centrum Medyczne" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Neoplasms" (2 trials), "Cardiac Failure" (1 trials) and "Congestive Heart Failure" (1 trials). Many other conditions were trialed in "BioVirtus Centrum Medyczne" in a lesser frequency.

Most popular intervention types in "BioVirtus Centrum Medyczne" are "Drug" (7 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (4 trials), "Placebo" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "BMS-986231" (1 trials). Other intervention names were less common.

The vast majority of trials in "BioVirtus Centrum Medyczne" are 8 trials for "All" genders.

Currently, there are NaN active trials in "BioVirtus Centrum Medyczne". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in BioVirtus Centrum Medyczne, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in BioVirtus Centrum Medyczne, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".